|
SI3093345T1
(sl)
*
|
2007-07-26 |
2019-08-30 |
Uniqure Ip B.V. |
Bakulovirusni vektorji, ki vsebujejo ponavljajoča kodirna zaporedja z različnimi kodonskimi preferencami
|
|
GB0911870D0
(en)
|
2009-07-08 |
2009-08-19 |
Ucl Business Plc |
Optimised coding sequence and promoter
|
|
WO2011112089A2
(en)
|
2010-03-11 |
2011-09-15 |
Amsterdam Molecular Therapeutics (Amt) Ip B.V. |
Mutated rep encoding sequences for use in aav production
|
|
WO2011122950A1
(en)
|
2010-04-01 |
2011-10-06 |
Amsterdam Molecular Therapeutics (Amt) Ip B.V. |
Monomeric duplex aav vectors
|
|
IT1400425B1
(it)
|
2010-06-08 |
2013-05-31 |
Amsterdam Molecular Therapeutics Bv |
Modified snrnas for use in therapy.
|
|
WO2012145509A2
(en)
*
|
2011-04-19 |
2012-10-26 |
The Research Foundation Of State University Of New York |
Adeno-associated-virus rep sequences, vectors, and viruses
|
|
GB201210357D0
(en)
|
2012-06-12 |
2012-07-25 |
Ucl Business Plc |
Factor VIII sequences
|
|
CN120174012A
(zh)
|
2013-10-24 |
2025-06-20 |
优尼科Ip有限公司 |
用于基因治疗神经疾病的aav-5假型载体
|
|
WO2015137802A1
(en)
*
|
2014-03-10 |
2015-09-17 |
Uniqure Ip B.V. |
Further improved aav vectors produced in insect cells
|
|
WO2015191508A1
(en)
|
2014-06-09 |
2015-12-17 |
Voyager Therapeutics, Inc. |
Chimeric capsids
|
|
SG11201703148TA
(en)
|
2014-11-05 |
2017-05-30 |
Voyager Therapeutics Inc |
Aadc polynucleotides for the treatment of parkinson's disease
|
|
GB201420139D0
(en)
|
2014-11-12 |
2014-12-24 |
Ucl Business Plc |
Factor IX gene therapy
|
|
CA3193811A1
(en)
|
2014-11-14 |
2016-05-19 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating amyotrophic lateral sclerosis (als)
|
|
CN119876138A
(zh)
|
2014-11-14 |
2025-04-25 |
沃雅戈治疗公司 |
调节性多核苷酸
|
|
FI3224376T4
(fi)
|
2014-11-28 |
2023-08-31 |
|
Dna-epäpuhtaudet koostumuksessa, joka käsittää parvovirusvirionin
|
|
HK1245326A1
(zh)
|
2014-12-12 |
2018-08-24 |
Voyager Therapeutics, Inc. |
用於生产scaav的组合物和方法
|
|
AU2015370903B2
(en)
|
2014-12-24 |
2021-06-17 |
Uniqure Ip B.V. |
RNAi induced huntingtin gene suppression
|
|
KR20230079511A
(ko)
|
2016-04-21 |
2023-06-07 |
바이로베크 인코포레이티드 |
곤충 세포에서의 aav 생산, 및 이를 위한 방법 및 조성물
|
|
EP3448874A4
(en)
|
2016-04-29 |
2020-04-22 |
Voyager Therapeutics, Inc. |
COMPOSITIONS FOR TREATING A DISEASE
|
|
EP3448987A4
(en)
|
2016-04-29 |
2020-05-27 |
Voyager Therapeutics, Inc. |
COMPOSITIONS FOR TREATING A DISEASE
|
|
CA3024448C
(en)
|
2016-05-18 |
2025-09-09 |
Voyager Therapeutics, Inc. |
MODULATING POLYNUCLEOTIDES
|
|
CA3024449A1
(en)
|
2016-05-18 |
2017-11-23 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating huntington's disease
|
|
PE20190401A1
(es)
*
|
2016-07-26 |
2019-03-13 |
Biomarin Pharm Inc |
Novedosas proteinas de la capside del virus adenoasociado
|
|
JP2019530737A
(ja)
|
2016-08-23 |
2019-10-24 |
アコーオス インコーポレイテッド |
ヒト対象において非加齢性聴力障害を治療するための組成物および方法
|
|
WO2018044933A1
(en)
|
2016-08-30 |
2018-03-08 |
The Regents Of The University Of California |
Methods for biomedical targeting and delivery and devices and systems for practicing the same
|
|
WO2018109207A1
(en)
|
2016-12-16 |
2018-06-21 |
Uniqure Ip B.V. |
Immunoadsorption
|
|
EP3618839A4
(en)
|
2017-05-05 |
2021-06-09 |
Voyager Therapeutics, Inc. |
COMPOSITIONS AND METHODS OF TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
|
|
JP2020518259A
(ja)
|
2017-05-05 |
2020-06-25 |
ボイジャー セラピューティクス インコーポレイテッドＶｏｙａｇｅｒ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
ハンチントン病治療組成物および方法
|
|
JOP20190269A1
(ar)
|
2017-06-15 |
2019-11-20 |
Voyager Therapeutics Inc |
بولي نوكليوتيدات aadc لعلاج مرض باركنسون
|
|
PT3652326T
(pt)
|
2017-07-10 |
2024-12-26 |
Uniqure Ip Bv |
Meios e métodos para terapia génica de aav em humanos
|
|
JP7229989B2
(ja)
|
2017-07-17 |
2023-02-28 |
ボイジャー セラピューティクス インコーポレイテッド |
軌道アレイガイドシステム
|
|
JP7221275B2
(ja)
|
2017-08-03 |
2023-02-13 |
ボイジャー セラピューティクス インコーポレイテッド |
Ａａｖを送達するための組成物および方法
|
|
US20200263199A1
(en)
|
2017-09-29 |
2020-08-20 |
Voyager Therapeutics, Inc. |
Rescue of central and peripheral neurological phenotype of friedreich's ataxia by intravenous delivery
|
|
TW202413649A
(zh)
|
2017-10-16 |
2024-04-01 |
美商航海家醫療公司 |
肌萎縮性脊髓側索硬化症(als)之治療
|
|
WO2019079242A1
(en)
|
2017-10-16 |
2019-04-25 |
Voyager Therapeutics, Inc. |
TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
|
|
CA3084452A1
(en)
|
2017-12-29 |
2019-07-04 |
Uniqure Ip B.V. |
Modified viral vectors and methods of making and using the same
|
|
SG11202006056RA
(en)
|
2018-01-17 |
2020-07-29 |
Meiragtx Uk Ii Ltd |
A modified raav capsid protein for gene therapy
|
|
GB201800903D0
(en)
|
2018-01-19 |
2018-03-07 |
Oxford Genetics Ltd |
Vectors
|
|
TW202015742A
(zh)
|
2018-05-15 |
2020-05-01 |
美商航海家醫療公司 |
投遞腺相關病毒（ａａｖ）之組成物和方法
|
|
SG11202011296VA
(en)
|
2018-05-15 |
2020-12-30 |
Voyager Therapeutics Inc |
Compositions and methods for the treatment of parkinson's disease
|
|
US12060567B2
(en)
|
2018-06-13 |
2024-08-13 |
Voyager Therapeutics, Inc. |
Engineered untranslated regions (UTR) for AAV production
|
|
US20210254103A1
(en)
|
2018-07-02 |
2021-08-19 |
Voyager Therapeutics, Inc. |
Treatment of amyotrophic lateral sclerosis and disorders associated with the spinal cord
|
|
AU2019310459A1
(en)
|
2018-07-24 |
2021-02-18 |
Voyager Therapeutics, Inc. |
Systems and methods for producing gene therapy formulations
|
|
US10842885B2
(en)
|
2018-08-20 |
2020-11-24 |
Ucl Business Ltd |
Factor IX encoding nucleotides
|
|
GB201813528D0
(en)
|
2018-08-20 |
2018-10-03 |
Ucl Business Plc |
Factor IX encoding nucleotides
|
|
EP3850098A1
(en)
|
2018-09-12 |
2021-07-21 |
uniQure IP B.V. |
Rnai induced c9orf72 suppression for the treatment of als/ftd
|
|
US20220125073A1
(en)
*
|
2018-09-20 |
2022-04-28 |
Tallgrass Biologics L.L.C. |
Treatment and control of colony collapse disorder
|
|
CN109295172A
(zh)
*
|
2018-09-26 |
2019-02-01 |
浙江海洋大学 |
大黄鱼清道夫受体家族基因的密码子偏好性分析方法
|
|
US12281321B2
(en)
|
2018-09-28 |
2025-04-22 |
Voyager Therapeutics, Inc. |
Frataxin expression constructs having engineered promoters and methods of use thereof
|
|
WO2020072849A1
(en)
|
2018-10-04 |
2020-04-09 |
Voyager Therapeutics, Inc. |
Methods for measuring the titer and potency of viral vector particles
|
|
WO2020072844A1
(en)
|
2018-10-05 |
2020-04-09 |
Voyager Therapeutics, Inc. |
Engineered nucleic acid constructs encoding aav production proteins
|
|
WO2020077165A1
(en)
|
2018-10-12 |
2020-04-16 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
|
CA3116701A1
(en)
|
2018-10-15 |
2020-04-23 |
Voyager Therapeutics, Inc. |
Expression vectors for large-scale production of raav in the baculovirus/sf9 system
|
|
WO2020104469A1
(en)
|
2018-11-19 |
2020-05-28 |
Uniqure Ip B.V. |
Method and means to deliver mirna to target cells
|
|
WO2020104295A1
(en)
|
2018-11-19 |
2020-05-28 |
Uniqure Ip B.V. |
Rnai induced reduction of ataxin-3 for the treatment of spinocerebellar ataxia type 3
|
|
CA3119721A1
(en)
|
2018-11-19 |
2020-05-28 |
Uniqure Ip B.V. |
A companion diagnostic to monitor the effects of gene therapy
|
|
WO2020104480A1
(en)
|
2018-11-19 |
2020-05-28 |
Uniqure Biopharma B.V. |
Adeno-associated virus vectors for expressing fviii mimetics and uses thereof
|
|
JP2022522995A
(ja)
|
2019-01-18 |
2022-04-21 |
ボイジャー セラピューティクス インコーポレイテッド |
Ａａｖ粒子を生成するための方法及びシステム
|
|
EP3962536A1
(en)
|
2019-04-29 |
2022-03-09 |
Voyager Therapeutics, Inc. |
Systems and methods for producing baculoviral infected insect cells (biics) in bioreactors
|
|
PL3999119T3
(pl)
|
2019-07-15 |
2025-02-10 |
Meiragtx Uk Ii Limited |
Modyfikowane białka kapsydu aav do leczenia choroby zapalnej stawów
|
|
WO2021030125A1
(en)
|
2019-08-09 |
2021-02-18 |
Voyager Therapeutics, Inc. |
Cell culture medium for use in producing gene therapy products in bioreactors
|
|
WO2021041375A1
(en)
*
|
2019-08-26 |
2021-03-04 |
Rootpath Genomics, Inc. |
Compositions and methods for producing adeno-associated viral vectors
|
|
TW202122582A
(zh)
|
2019-08-26 |
2021-06-16 |
美商航海家醫療公司 |
病毒蛋白之控制表現
|
|
WO2021053018A1
(en)
|
2019-09-16 |
2021-03-25 |
Uniqure Ip B.V. |
Targeting misspliced transcripts in genetic disorders
|
|
IL293397A
(en)
*
|
2019-12-04 |
2022-07-01 |
Sangamo Therapeutics Inc |
New preparations and methods for the production of recombinant aav
|
|
JP7807380B2
(ja)
|
2020-02-21 |
2026-01-27 |
アコーオス インコーポレイテッド |
ヒト対象において非加齢関連聴力障害を処置するための組成物および方法
|
|
WO2021195491A2
(en)
*
|
2020-03-26 |
2021-09-30 |
Asklepios Biopharmaceutical, Inc. |
Inducible promoter for viral vector production
|
|
EP4127135A1
(en)
|
2020-04-02 |
2023-02-08 |
uniQure biopharma B.V. |
Dual bifunctional vectors for aav production
|
|
JP2023519138A
(ja)
*
|
2020-04-02 |
2023-05-10 |
ユニキュアー バイオファーマ ビー．ブイ． |
新規細胞株
|
|
CA3174872A1
(en)
|
2020-04-07 |
2021-10-14 |
Sander Jan Hendrik Van Deventer |
Gene constructs for silencing angiopoietin-like 3 (angptl3) and uses thereof
|
|
MX2022012752A
(es)
|
2020-04-15 |
2023-01-16 |
Voyager Therapeutics Inc |
Compuestos de union a tau.
|
|
BR112023001456A2
(pt)
|
2020-07-27 |
2023-04-11 |
Voyager Therapeutics Inc |
Composições e métodos para o tratamento de distúrbios neurológicos relacionados à deficiência de beta glicosilceramidase
|
|
US20230285596A1
(en)
|
2020-07-27 |
2023-09-14 |
Voyager Therapeutics, Inc |
Compositions and methods for the treatment of niemann-pick type c1 disease
|
|
WO2022032153A1
(en)
|
2020-08-06 |
2022-02-10 |
Voyager Therapeutics, Inc. |
Cell culture medium for use in producing gene therapy products in bioreactors
|
|
US20240141377A1
(en)
|
2021-03-03 |
2024-05-02 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
US20240141378A1
(en)
|
2021-03-03 |
2024-05-02 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
CN115427561B
(zh)
|
2021-03-09 |
2024-06-04 |
辉大(上海)生物科技有限公司 |
工程化CRISPR/Cas13系统及其用途
|
|
WO2022214635A1
(en)
|
2021-04-08 |
2022-10-13 |
Stichting Vu |
Nucleic acid molecules for compensation of stxbp1 haploinsufficiency and their use in the treatment of stxbp1-related disorders
|
|
AU2022286647A1
(en)
|
2021-06-02 |
2023-11-30 |
Uniqure Biopharma B.V. |
Insect cell production of parvoviral vectors with modified capsid proteins
|
|
CA3219847A1
(en)
|
2021-06-02 |
2022-12-08 |
Sander Jan Hendrik Van Deventer |
Adeno-associated virus vectors modified to bind high-density lipoprotein
|
|
EP4359525A1
(en)
|
2021-06-21 |
2024-05-01 |
uniQure biopharma B.V. |
Gene constructs for silencing alpha-synuclein and uses thereof
|
|
CN117836010A
(zh)
|
2021-06-21 |
2024-04-05 |
优尼科生物制药有限公司 |
改进的裂解程序
|
|
WO2023283962A1
(en)
|
2021-07-16 |
2023-01-19 |
Huigene Therapeutics Co., Ltd. |
Modified aav capsid for gene therapy and methods thereof
|
|
CA3227296A1
(en)
*
|
2021-07-28 |
2023-02-02 |
Tomas Cinek |
Large scale adeno-associated virus production systems
|
|
CN117716044A
(zh)
*
|
2021-07-28 |
2024-03-15 |
生物马林药物股份有限公司 |
大规模腺相关病毒生产系统
|
|
US20250297278A1
(en)
|
2021-08-26 |
2025-09-25 |
Uniqure Biopharma B.V. |
Insect cell-produced high potency AAV vectors with CNS-tropism
|
|
EP4433490A2
(en)
|
2021-11-17 |
2024-09-25 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of neurological disorders related to glucosylceramidase beta deficiency
|
|
EP4469585A2
(en)
|
2022-01-25 |
2024-12-04 |
Voyager Therapeutics, Inc. |
Baculovirus expression system
|
|
CN114703203B
(zh)
*
|
2022-02-11 |
2024-08-06 |
上海渤因生物科技有限公司 |
杆状病毒载体及其用途
|
|
WO2023198702A1
(en)
|
2022-04-12 |
2023-10-19 |
Uniqure Biopharma B.V. |
Nucleic acid regulation of c9orf72
|
|
EP4508213A1
(en)
|
2022-04-12 |
2025-02-19 |
uniQure biopharma B.V. |
Nucleic acid regulation of apoe
|
|
EP4508215A1
(en)
|
2022-04-12 |
2025-02-19 |
uniQure biopharma B.V. |
Novel systems for nucleic acid regulation
|
|
WO2023198663A1
(en)
|
2022-04-12 |
2023-10-19 |
Uniqure Biopharma B.V. |
Nucleic acid regulation of snca
|
|
WO2023240236A1
(en)
|
2022-06-10 |
2023-12-14 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of spinal muscular atrophy related disorders
|
|
US20260085328A1
(en)
|
2022-09-08 |
2026-03-26 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
JPWO2024143440A1
(https=)
|
2022-12-28 |
2024-07-04 |
|
|
|
AU2023427408A1
(en)
|
2023-02-02 |
2025-09-04 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of neurological disorders related to glucosylceramidase beta deficiency
|
|
WO2024218204A1
(en)
|
2023-04-18 |
2024-10-24 |
Uniqure Biopharma B.V. |
Gene delivery vehicles comprising rna and antibodies
|
|
EP4698555A1
(en)
|
2023-04-18 |
2026-02-25 |
uniQure biopharma B.V. |
Novel neurotropic adeno-associated virus capsids with detargeting of peripheral organs
|
|
WO2024218190A1
(en)
|
2023-04-18 |
2024-10-24 |
Uniqure Biopharma B.V. |
Generation of adeno-associated virus capsid libraries for insect cells
|
|
WO2024226761A2
(en)
|
2023-04-26 |
2024-10-31 |
Voyager Therapeutics, Inc. |
Compositions and methods for treating amyotrophic lateral sclerosis
|
|
AU2024313758A1
(en)
|
2023-06-23 |
2026-01-08 |
Uniqure Biopharma B.V. |
Novel fragile x constructs
|
|
TW202525832A
(zh)
|
2023-08-31 |
2025-07-01 |
美商戴諾治療公司 |
衣殼多肽及其使用方法(二)
|
|
AU2024337260A1
(en)
|
2023-09-04 |
2026-03-12 |
Uniqure Biopharma B.V. |
Novel neurotropic recombinant adeno-associated virus particles
|
|
AU2024357870A1
(en)
|
2023-10-11 |
2026-04-23 |
Uniqure Biopharma B.V. |
Further novel systems for nucleic acid regulation
|
|
WO2025078602A1
(en)
|
2023-10-11 |
2025-04-17 |
Uniqure Biopharma B.V. |
Nucleic acid regulation of msh3 in repeat expansion disorders
|
|
AU2024360616A1
(en)
|
2023-10-11 |
2026-04-23 |
Uniqure Biopharma B.V. |
Novel nucleic acid regulation of huntingtin gene
|
|
WO2025114524A1
(en)
|
2023-11-30 |
2025-06-05 |
Uniqure Biopharma B.V. |
Formulations for viral drug products
|
|
TW202545971A
(zh)
|
2024-02-08 |
2025-12-01 |
美商戴諾治療公司 |
殼體多肽及其使用方法
|
|
WO2025219443A1
(en)
|
2024-04-19 |
2025-10-23 |
Uniqure Biopharma B.V. |
Nucleic acid for a1at regulation
|
|
WO2026041788A1
(en)
|
2024-08-22 |
2026-02-26 |
Uniqure Biopharma B.V |
Novel bbb interacting capsids
|
|
WO2026041782A1
(en)
|
2024-08-22 |
2026-02-26 |
Uniqure Biopharma B.V. |
Novel raav capsids
|
|
WO2026064442A2
(en)
|
2024-09-18 |
2026-03-26 |
Dyno Therapeutics, Inc. |
Capsid polypeptides and methods of use thereof
|
|
WO2026064428A2
(en)
|
2024-09-18 |
2026-03-26 |
Dyno Therapeutics, Inc. |
Capsid polypeptides and methods of use thereof
|
|
WO2026064444A1
(en)
|
2024-09-18 |
2026-03-26 |
Dyno Therapeutics, Inc. |
Capsid polypeptides and methods of use thereof
|